Know the market
before the deal.
TAM/SAM/SOM, competitive landscapes, partner scoring, and regulatory pathway analysis — sourced, methodology-backed, and board-presentation-ready. For biotech professionals who can't wait 3 weeks for a consulting deliverable.
KRAS G12C Inhibitor · NSCLC · Phase 2
Generated in 4.2s · ClinicalTrials.gov + FDA data · High confidence
Powered by live data pipelines
Built For
Intelligence for every seat at the table.
Whether you're building the company, doing the deal, or writing the check — Terrain gives you the market context to move with conviction.
Biotech Founders & CEOs
Series A–C
“You’re raising a round, negotiating a licensing deal, or evaluating a pipeline pivot — and you need defensible market data in 48 hours, not 3 weeks from a consulting firm.”
Terrain delivers board-grade TAM/SAM/SOM, competitive crowding scores, and partner fit rankings in under 10 minutes. Every number is sourced. Every chart is presentation-ready.
BD & Licensing Executives
Pharma & Biotech
“You evaluate 8–12 opportunities per quarter. Each one needs a market assessment before the term sheet — and your analysts are perpetually bottlenecked on the last deal.”
Run unlimited analyses across indications, geographies, and product categories. Export deal-ready PDFs with competitive landscapes, deal-term benchmarks from 10,000+ transactions, and regulatory timelines.
Life Sciences Investors
VC, Crossover & PE
“You have 40 companies in your pipeline and need to separate the $10B opportunities from the $500M niches before writing the check — without waiting on an associate’s desk research.”
Validate market size in minutes, not weeks. Compare competitive density across indications, benchmark deal terms against actual transaction data, and export for your investment committee.
Built by Ambrosia Ventures — life sciences M&A and strategy advisory. Our deal experience is embedded in every calculation.
Intelligence Modules
Four modules. One platform.
Every module answers the questions that precede licensing deals, M&A transactions, and partnership discussions.
Market Sizing
Patient-funnel TAM/SAM/SOM with biomarker-specific subtypes, 10-year revenue projections, and geography breakdown. Pharma, devices, diagnostics, and nutraceuticals.
Competitive Landscape
Pipeline mapping with crowding scores, head-to-head comparisons, and deal-value context. Powered by live ClinicalTrials.gov and FDA data updated nightly.
Partner Discovery
Algorithmic matching to 300+ biopharma and medtech BD groups scored on therapeutic alignment, pipeline gaps, deal history, and financial capacity.
Regulatory Intelligence
FDA/EMA/PMDA pathway recommendation, designation eligibility, timeline benchmarking, and reimbursement strategy for drugs, devices, and diagnostics.
How It Works
From question to answer in three steps.
Select product & indication
Choose your product category (pharmaceutical, device, diagnostic, or nutraceutical) and indication. Specify biomarker subtype, geography, and development stage.
Generate your analysis
Terrain runs patient-funnel market sizing, maps the competitive pipeline from live ClinicalTrials.gov data, scores partner matches against 10K+ deal terms, and recommends regulatory pathways — in under 30 seconds.
Export & act
Download institutional-grade PDFs and CSVs. Every number is sourced. Every chart is presentation-ready for board decks, investment memos, and licensing committee deliverables.
Live Calculator
See your market in real time.
Pick any therapeutic area, indication, and development stage. Terrain computes TAM, SAM, SOM, and peak sales estimates instantly — the same engine powering our full intelligence reports.
- 10 therapeutic areas, 20+ indications pre-loaded
- Stage-adjusted market share modeling
- Epidemiology-driven patient funnel
- Full reports cover 15+ analytics sections
Get the full report with 15+ analytics sections — patient funnel, competitive landscape, partner matching, regulatory pathway, and deal benchmarks.
Sign up freeWhy Terrain
Replace a $500K engagement with a $149/mo subscription.
Terrain delivers institutional-grade market intelligence at a fraction of the cost and time of traditional consulting — with broader coverage, real-time data, and instant updates.
The Difference
Traditional consulting vs. Terrain
See It In Action
Institutional-grade intelligence, delivered instantly.
Every analysis produces a comprehensive report with sourced data, exportable charts, and presentation-ready formatting.
Seconds, not weeks
Full TAM/SAM/SOM with patient funnel, competitive landscape, and partner scoring in under 30 seconds. The same deliverable a consulting firm charges $50K for and takes 3 weeks to produce.
Global coverage, any modality
US, EU5, Japan, China, and Rest of World. Pharmaceuticals, medical devices, diagnostics, and nutraceuticals — each with category-specific sizing, regulatory pathways, and reimbursement models.
Deal-ready output
Export to PDF or CSV with institutional-grade formatting. Every number is sourced. Every chart is presentation-ready for board decks, investment committee memos, and licensing discussions.
Pricing
Intelligence at every scale
Start free. Upgrade when Terrain becomes indispensable.
Free
Explore the platform with core market intelligence.
- 3 market sizing reports / month
- 1 competitive landscape / month
- Limited partner discovery
- 3 saved reports
- US geography only
Pro
Full intelligence suite for active deal-makers.
14-day free trial · No credit card required
- Unlimited market sizing
- Unlimited competitive landscapes
- Full partner discovery engine
- Regulatory intelligence
- Live market intelligence feeds
- PDF & CSV export
- Global geography coverage
- Unlimited saved reports
Team
Shared intelligence for deal teams and BD groups.
- Everything in Pro
- 10 team seats included
- Shared workspace & report library
- Report folders & organization
- Team activity feed
- Collaborative annotations
- Side-by-side report comparison
- Team analytics dashboard
- Report templates
- Co-branded PDF & Excel exports
- Priority support
Enterprise
Custom intelligence infrastructure for large organizations.
- Everything in Team
- Unlimited seats
- REST API with key management
- SSO / SAML (Okta, Azure AD)
- Comprehensive audit log
- Role-based access control
- Information barriers (deal rooms)
- White-label reports
- Dedicated customer success manager
- SLA & enterprise security review
FAQ
Common questions
Five primary sources: ClinicalTrials.gov (live competitive pipeline), FDA/EMA approval databases, SEC EDGAR filings (partnership and deal disclosures, AI-extracted), WHO Global Burden of Disease (epidemiology), and a proprietary database of 10,000+ biopharma M&A and licensing transactions built by Ambrosia Ventures.
ClinicalTrials.gov data updates nightly via automated pipelines. FDA approvals and SEC EDGAR filings are processed within 24 hours. Epidemiology and pricing benchmarks are updated quarterly. Pro users get access to live market intelligence feeds with data source health dashboards.
Yes. Every output includes a methodology section and data sources footer with specific citations. The patient-funnel methodology (prevalence → diagnosed → treated → addressable → capturable) follows the same framework used by top-tier equity research analysts at Goldman Sachs and Morgan Stanley.
Yes. Terrain tracks 204 biomarkers across oncology, neurology, immunology, and other therapeutic areas. You can size markets for specific subtypes — for example, EGFR-mutant NSCLC or HER2-low breast cancer — with prevalence-adjusted patient funnels and subtype-specific competitive landscapes.
Four product categories: pharmaceuticals, medical devices (implantable, surgical, SaMD), in vitro diagnostics (IVD/CDx), and nutraceuticals. Each category uses the appropriate sizing methodology — patient funnels for drugs, procedure volumes for devices, test volumes for diagnostics — with category-specific regulatory pathways and partner databases.
Pro is for individual professionals — unlimited analyses, full module access, live market intelligence feeds, and export capabilities. Team adds 5 seats, a shared report library, API access, and a team analytics dashboard for BD groups working collaboratively.
236 indications across 18 therapeutic areas including oncology, neurology, immunology, rare disease, cardio-metabolic, GI, rheumatology, endocrinology, and more. Each indication includes detailed subtypes, biomarker profiles, standard-of-care data, and competitive intelligence.
Terrain runs on Supabase (PostgreSQL) with row-level security, encrypted at rest and in transit. Your analyses and saved reports are only visible to your account (or your team on the Team plan). We never share or sell user data.
Your next deal starts with better data.
Join biotech founders, BD executives, and life sciences investors who use Terrain to move faster and negotiate smarter.
No credit card required · Set up in under 2 minutes